Share：
Share this content in WeChat
X
[Chinese][PDF]1049103
• Experience Exchanges •
The value of Gd-EOB-DTPA enhanced MRI in predicting microvascular invasion of hepatocellular carcinoma and its grade
WANG Jing  ZHENG Jin  SUN Jun  SHEN Li 

Cite this article as: Wang J, Zheng J, Sun J, et al. The value of Gd-EOB-DTPA enhanced MRI in predicting microvascular invasion of hepatocellular carcinoma and its grade[J]. Chin J Magn Reson Imaging, 2021, 12(12): 79-83, 88. DOI:10.12015/issn.1674-8034.2021.12.016.


[Abstract] Objective To evaluate the predictive value of Gd-EOB-DTP-enhanced MRI in the occurrence and grading of microvascular invasion of (MVI) in hepatocellular carcinoma (HCC). Materials and Methods: Sixty-seven patients with primary HCC confirmed by postoperative pathology were retrospectively studied. All cases were divided into MVI positive group and MVI negative group according to whether there was microvascular invasion or not. The general data and laboratory examination, Gd-EOB-DTPA enhanced MRI imaging data and postoperative tumor histopathological grading data were analyzed, and the independent risk factors affecting microvascular invasion in patients with hepatocellular carcinoma were obtained. ROC curve was drawn to evaluate the diagnostic efficacy of independent risk factors. Furthermore, according to the histological characteristics of microvascular invasion, all patients with hepatocellular carcinoma were divided into M0 group, M1 group and M2 group. The effect of P＜0.05 in univariate analysis on MVI grade was studied.Results Univariate analysis showed that there were significant differences in tumor margin、rim enhancement、peritumoral enhancement in arterial phase and peritumoral hypointensity in the hepatobiliary phase between MVI positive group and MVI negative group. Further multivariate Logistic regression analysis showed that peritumoral enhancement in the arterial phase and peritumoral hypointensity in the hepatobiliary phase were independent risk factors for the occurrence of MVI in hepatocellular carcinoma. The results of diagnostic effectiveness analysis of independent risk factors showed that the area under the curve (AUC) of peritumoral enhancement in the arterial phase and peritumoral hypointensity in the hepatobiliary phase were 0.669 and 0.636, respectively. The sensitivity and specificity of peritumoral enhancement in the arterial phase were 93.8% and 40.0%, respectively, and the sensitivity and specificity of peritumoral hypointensity in the hepatobiliary phase were 84.4% and 42.9%, respectively. Furthermore, all patients with hepatocellular carcinoma were divided into M0 group, M1 group and M2 group according to MVI grade. The results showed that there were significant differences in peritumor rim enhancement in arterial phase, low signal intensity in hepatobiliary phase and tumor margin among different MVI grades, and it can be seen from the data that the higher the MVI grade, the greater the proportion of peritumoral enhancement in the arterial phase and peritumoral hypointensity in the hepatobiliary phase.Conclusions In Gd-EOB-DTPA enhanced MRI, peritumoral enhancement in the arterial phase and peritumoral hypointensity in the hepatobiliary phase can be used as effective indexes to predict microvascular invasion of HCC before operation, while peritumoral enhancement in the arterial phase and peritumoral hypointensity in the hepatobiliary phase and tumor margin can be used to predict MVI grade of HCC.
[Keywords] primary hepatocellular carcinoma；microvascular invasion；gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid；magnetic resonance imaging；risk factors

WANG Jing   ZHENG Jin*   SUN Jun   SHEN Li  

Department of Radiology, Subei People's Hospital, the Clinical Medical College of Yangzhou University, Yangzhou 225001, China

Zheng J, E-mail: zhj65220@163.com

Conflicts of interest   None.

Received  2021-07-05
Accepted  2021-10-12
DOI: 10.12015/issn.1674-8034.2021.12.016
Cite this article as: Wang J, Zheng J, Sun J, et al. The value of Gd-EOB-DTPA enhanced MRI in predicting microvascular invasion of hepatocellular carcinoma and its grade[J]. Chin J Magn Reson Imaging, 2021, 12(12): 79-83, 88. DOI:10.12015/issn.1674-8034.2021.12.016.

[1]
Villanueva A. Hepatocellular Carcinoma[J]. N Engl J Med, 2019, 380(15): 1450-1462. DOI: 10.1056/NEJMra1713263.
[2]
Chen SL, Xiao H, Xie ZL, et al. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC[J]. Eur Radiol, 2020, 30(6): 3473-3485. DOI: 10.1007/s00330-019-06640-8.
[3]
Nitta H, Allard MA, Sebagh M, et al. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma[J]. Ann Surg Oncol, 2019, 26(8): 2568-2576. DOI: 10.1245/s10434-019-07365-0.
[4]
Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria[J]. Ann Surg, 2011, 254(1): 108-113. DOI: 10.1097/SLA.0b013e31821ad884.
[5]
Zhang WB, Deng YL, Zhao LS. Analysis of risk factors for hepatocellular carcinoma with MVI[J]. Henan Journal of Surgery, 2020, 26(2): 18-22. DOI: 10.16193/j.cnki.hnwk.2020.02.007.
[6]
Cong WM, Bu H, Chen J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update[J]. World J Gastroenterol, 2016, 22(42): 9279-9287. DOI: 10.3748/wjg.v22.i42.9279.
[7]
Wei W, Du JK, Zhang WX. Predictive risk factors for microvascular invasion of hepatocellular carcinoma[J]. The Journal of Medical Theory and Practice, 2021, 34(5): 752-754. DOI: 10.19381/j.issn.1001-7585.2021.05.010.
[8]
Ding GY, Zhu XD, Shi GM, et al. Clinical values of microvascular invasion for recurrent hepatocellular carcinoma patients after radical hepatic resections[J]. Journal of Hepatopancreatobiliary Surgery, 2018, 30(3): 182-186. DOI: 10.11952/j.issn.1007-1954.2018.03.002.
[9]
Sumie S, Nakashima O, Okuda K, et al. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma[J]. Ann Surg Oncol, 2014, 21(3): 1002-1009. DOI: 10.1245/s10434-013-3376-9.
[10]
Kaibori M, Ishizaki M, Matsui K, et al. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma[J]. J Surg Oncol, 2010, 102(5): 462-468. DOI: 10.1002/jso.21631.
[11]
Liu YQ, Zhao XX. Risk factors for predicting the grade of microvascular invasion in primary hepatocellular carcinoma[J]. Radiologic Practice, 2020, 35(11): 1453-1457. DOI: 10.13609/j.cnki.1000-0313.2020.11.016.
[12]
Iguchi T, Shirabe K, Aishima S, et al. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation[J]. Transplantation, 2015, 99(6): 1236-1242. DOI: 10.1097/TP.0000000000000489.
[13]
Shen J, Wen J, Li C, et al. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis[J]. BMC Cancer, 2018, 18(1): 278. DOI: 10.1186/s12885-018-4196-x.
[14]
Li T, Li HM, Wang WG, et al. Analysis of Risk Factors of Microvascular Infiltration in Hepatocellular Carcinoma Caused by Hepatitis B Virus Infection[J]. Ningxia Medical University, 2021,43(5): 493-497. DOI: 10.16050/j.cnki.issn1674-6309.2021.05.010.
[15]
Eguchi S, Takatsuki M, Hidaka M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection[J]. World J Surg, 2010, 34(5): 1034-1038. DOI: 10.1007/s00268-010-0424-5.
[16]
Chandarana H, Robinson E, Hajdu CH, et al. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?[J]. AJR Am J Roentgenol, 2011, 196(5): 1083-1089. DOI: 10.2214/AJR.10.4720.
[17]
Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma[J]. Hepatology, 2015, 62(3): 792-800. DOI: 10.1002/hep.27877.
[18]
Zhang C, Zhao QJ. Influencing prognostic factors anlysis of microvascular invasion patients with hepatocellular carcinoma[J]. Inner Mongolia Medical Journal, 2021, 53(5): 518-521. DOI: 10.16096/J.cnki.nmgyxzz.2021.53.05.002.
[19]
Ye KQ, Hua XP, Huang JZ. Progress on preoperative prediction of microvascular invasion in hepatocellular carcinoma[J]. Chinese Journal of Liver Disease (Electronic Version), 2021, 13(1): 27-31. DOI: 10.3969/j.issn.1674-7380.2021.01.005.
[20]
Wu TH, Hatano E, Yamanaka K, et al. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma[J]. Surg Today, 2016, 46(11): 1275-1281. DOI: 10.1007/s00595-016-1320-x.
[21]
An C, Kim DW, Park YN, et al. Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection[J]. Radiology, 2015, 276(2): 433-443. DOI: 10.1148/radiol.15142394.
[22]
Xu YK, Cheng TM, Liu XY, et al. Prelimanary study on the relationship between CT marginal features of massive hepatocellular carcinoma and intratumorous crovascular density[J]. Radiol Pract, 2000(1): 30-32. DOI: 10.13609/j.cnki.1000-0313.2000.01.020.
[23]
Lee S, Kim SH, Lee JE, et al. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma[J]. J Hepatol, 2017, 67(3): 526-534. DOI: 10.1016/j.jhep.2017.04.024.
[24]
Kim JY, Kim MJ, Kim KA, et al. Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features[J]. Eur J Radiol, 2012, 81(12): 3877-3882. DOI: 10.1016/j.ejrad.2012.07.021.

PREV The value of IVIM-DWI combined with Gd-EOB-DTPA enhanced MRI in prediction of hepatocellular carcinoma microvascular invasion
NEXT A comparative study of UTE and T2* mapping imaging technology in quantitative assessment of rotator cuff tear
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn